Connect with us

Finance

FDA Scientists Say Benefits of Pfizer Covid-19 Vaccine ‘clearly Outweigh’ the Risks for Children Ages 5 to 11

Edward Drake

Published

on

Scientists at the Food and Drug Administration presented an analysis late Friday showing that the protection offered to children between the ages of 5 and 11 by the Covid vaccine developed by Pfizer and BioNTech “would clearly outweigh” the risk of myocarditis, a heart-related side effect, that the vaccine appears to cause.

The FDA’s analysis was made public ahead of a Tuesday meeting of outside scientists convened to make a recommendation on authorizing the vaccine for children in that age range. An agenda for the meeting shows sessions dedicated to the vaccine’s effectiveness, and to the potential risk of myocarditis, an inflammation of the heart. The FDA is not bound by the votes of its advisory committees, but it generally follows their advice.

Read the rest…

Source Here: statnews.com

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published.

Finance

Unichem Labs Surges 15% on ANDA Nod From USFDA for Aripiprazole Tablets

Edward Drake

Published

on

Aripiprazole tablets are indicated for Schizophrenia and Irritability associated with Autistic Disorder

Original Article: business-standard.com

Continue Reading

Finance

PowerGrid Hits Record High, Gains 4%; Stock Has Rallied 18% in Last 3 Weeks

Edward Drake

Published

on

PowerGrid has a robust project pipeline worth Rs 27,500 crore and has capitalised around Rs 22,932 crore in the last four quarters, which provides earnings visibility for 2-3 years

Source: business-standard.com

Continue Reading

Finance

Vodafone Idea Surges 21% in Two Days, Stock Nears 52-week High

Edward Drake

Published

on

In the past two weeks, the stock has surged 34 per cent after the telecom service provider increased its prepaid tariff by 20-25 per cent from November 25, 2021

Source: business-standard.com

Continue Reading

Trending

AggroNews.com